Anixa Biosciences, Inc. (ANIX)

3.62 -0.09 (-2.43%) USD  |  NASDAQ  |  Aug 24, 16:00
3.62 0.00 (0.00%) After-Hours: 20:00
More

Anixa Biosciences EV to Revenues

EV to Revenues Chart

View EV to Revenues for ANIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical EV to Revenues Data

View and export this data back to 1999. Start Trial.
Date Value
April 29, 2024 --
April 26, 2024 --
April 25, 2024 --
April 24, 2024 --
April 23, 2024 --
April 22, 2024 --
April 19, 2024 --
April 18, 2024 --
April 17, 2024 --
April 16, 2024 --
April 15, 2024 --
April 12, 2024 --
April 11, 2024 --
April 10, 2024 --
April 09, 2024 --
April 08, 2024 --
April 05, 2024 --
April 04, 2024 --
April 03, 2024 --
April 02, 2024 --
April 01, 2024 --
March 28, 2024 --
March 27, 2024 --
March 26, 2024 --
March 25, 2024 --
Date Value
March 22, 2024 --
March 21, 2024 --
March 20, 2024 --
March 19, 2024 --
March 18, 2024 --
March 15, 2024 --
March 14, 2024 --
March 13, 2024 --
March 12, 2024 --
March 11, 2024 --
March 08, 2024 --
March 07, 2024 --
March 06, 2024 --
March 05, 2024 --
March 04, 2024 --
March 01, 2024 --
February 29, 2024 --
February 28, 2024 --
February 27, 2024 --
February 26, 2024 --
February 23, 2024 --
February 22, 2024 --
February 21, 2024 --
February 20, 2024 --
February 16, 2024 --

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Vicapsys Life Sciences, Inc. --

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade